News27 Aug 2026
MalariaGEN awarded Phase 3 Gates Foundation grant to accelerate malaria vaccine translation
Dr Jacob Almagro-Garcia, Translational Research Lead at MalariaGEN, has been awarded a new Phase 3 grant from the Gates Foundation, marking an exciting next step in MalariaGEN's efforts to turn large-scale genomic and computational research into practical tools for malaria vaccine development.